Lataa...
(89)Zr-ImmunoPET Companion Diagnostics and their Impact in Clinical Drug Development
Therapeutic monoclonal antibodies (mAbs) have been used in cancer treatment for 30 years, with around 24 mAb and mAb:drug conjugates approved by the FDA to date. Despite their specificity, efficacy has remained limited, which, in part, derails nascent initiatives towards precision medicine. An image...
Tallennettuna:
| Julkaisussa: | J Labelled Comp Radiopharm |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050145/ https://ncbi.nlm.nih.gov/pubmed/29341222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jlcr.3605 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|